OM (Outset Medical) Notes Receivable: $0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OM Outset Medical Inc OM
64 GF Score
Price $4.74
GF Value $4.18
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Outset Medical Notes Receivable?

Outset Medical OM -8.51% 64 Notes Receivable is $0.0 Mil as of Jun. 2026. GuruFocus rates OM with a GF Score™ of 64/100 and a GF Value™ of $4.18 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Outset Medical's Notes Receivable for the quarter that ended in Jun. 2026 was $0.0 Mil.

Outset Medical Notes Receivable Historical Data

* Premium members only.

The historical data trend for Outset Medical's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Outset Medical Notes Receivable Chart

Outset Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Outset Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OM
64GF Score
Outset Medical Inc OM
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Outset Medical Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.0 Mil mean?
Outset Medical (OM) has a Notes Receivable of $0.0 Mil as of Jun. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Outset Medical and its competitors.
Is Outset Medical's Notes Receivable too high?
Outset Medical's current Notes Receivable is $0.0 Mil. Overall, Outset Medical has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Outset Medical's Notes Receivable compare to SERA and LNSR?
Outset Medical's Notes Receivable of $0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Outset Medical and its competitors. Outset Medical's current Notes Receivable is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Outset Medical stock overvalued right now?
Based on GuruFocus' analysis, Outset Medical (OM) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.18, compared to a current price of $4.74 — trading 13.4% above its estimated fair value. The current Notes Receivable is $0.0 Mil. Outset Medical's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Outset Medical (OM), the current Notes Receivable is $0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Outset Medical (OM) Overvalued in 2026?

Based on GuruFocus' analysis, Outset Medical stock appears to be overvalued. The current stock price of $4.74 is trading 13.4% above its estimated GF Value™ of $4.18. GuruFocus considers Outset Medical to be Modestly Overvalued.

Key valuation signals for OM:

  • Notes Receivable: $0.0 Mil
  • GF Value™: $4.18 vs. price of $4.74 (13.4% above fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the OM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Outset Medical Business Description

Address 3052 Orchard Drive, San Jose, CA, USA, 95134
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
64GF Score

Get the complete analysis for OM

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.74
Price
$4.18
GF Value